Reuters logo
BRIEF-Albireo reports 2016 financial results
March 14, 2017 / 11:38 AM / 8 months ago

BRIEF-Albireo reports 2016 financial results

March 14 (Reuters) - Albireo Pharma Inc-

* Albireo reports 2016 financial results

* Expects that its current cash resources will be sufficient to meet its operating requirements at least through mid 2018

* Cash guidance assumes receipt of a contingent milestone payment under Albireo’s license agreement with Ea Pharma

* Expects to initiate its planned phase 3 trial of a4250 in patients with pfic in second half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below